WordNet

swim in or form a large group of fish; "A cluster of schooling fish was attracted to the bait"
the period of instruction in a school; the time period when school is in session; "stay after school"; "he didnt miss a single day of school"; "when the school day was done we would walk home together" (同)schooltime, school_day
a building where young people receive education; "the school was built in 1932"; "he walked to school every morning" (同)schoolhouse
the process of being formally educated at a school; "what will you do when you finish school?" (同)schooling
a large group of fish; "a school of small glittering fish swam by" (同)shoal
a body of creative artists or writers or thinkers linked by a similar style or by similar teachers; "the Venetian school of painting"
an educational institution; "the school was founded in 1900"
an educational institutions faculty and students; "the school keeps parents informed"; "the whole school turned out for the game"
educate in or as if in a school; "The children are schooled at great cost to their parents in private institutions"
requiring or amenable to treatment by medicine especially as opposed to surgery; "medical treatment"; "pneumonia is a medical disease"
relating to the study or practice of medicine; "the medical profession"; "a medical student"; "medical school"
a way of doing something, especially a systematic way; implies an orderly logical arrangement (usually in steps)
a permanent organization of the military land forces of a nation or state (同)regular army, ground forces
a large number of people united for some specific purpose
the 9th letter of the Roman alphabet (同)i

PrepTutorEJDIC

〈C〉(施設としての)『学校』 / 〈C〉(大学の)『学部』 / 〈C〉教習所,養成所,訓練所 / 〈C〉『校舎』,学校の建物 / 〈U〉《冠詞をつけないで》『授業』[『時間』]課業 / 〈U〉《冠詞をつけないで》学校教育,学業 / 《the~》《集合的に》全校生徒および教職員 / 〈C〉(学問・芸術などの)『派』,学派,流派 / 〈人〉‘を'教育する,‘に'教える / …‘を'しつける,訓練する
(魚・鯨などの)群れ《+『of』+『名』》
『医学の』,医術の;医者の / 内科の;内科治療を要する / 診察
〈C〉(特に秩序だった)(…の)『方法』,方式《+『of』+『名』(do『ing』)》 / 〈C〉〈U〉(思考行・行為・行動の)きちょうめんさ;秩序,筋道
《ときにA-》『陸軍』 / 《the A-》軍隊;(一国の全)軍隊 / (共通の主義・主張のために組織された)(…の)『団体』,集団《+『of』+『名』》 / (人・動物などの)大群《+『of』+『名』》
『私は』私が
iodineの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 米国の小児における学校の準備 school readiness for children in the united states
2. 避妊カウンセリングと選択 contraceptive counseling and selection
3. 胸腔鏡の概要 an overview of medical thoracoscopy
4. ステージIII非小細胞肺癌のマネージメント management of stage iii non small cell lung cancer
5. 肥大型心筋症：内科的治療 hypertrophic cardiomyopathy medical therapy

English Journal

Remodeling characteristics and collagen distribution in biological scaffold materials explanted from human subjects after abdominal soft tissue reconstruction: an analysis of scaffold remodeling characteristics by patient risk factors and surgical site classifications.

Cavallo JA1, Roma AA, Jasielec MS, Ousley J, Creamer J, Pichert MD, Baalman S, Frisella MM, Matthews BD, Deeken CR.
Annals of surgery.Ann Surg.2015 Feb;261(2):405-15. doi: 10.1097/SLA.0000000000000471.
OBJECTIVE: The study purpose was to evaluate the associations between patient characteristics or surgical site classifications and the histologic remodeling scores of biologic meshes biopsied from abdominal soft tissue repair sites in the first attempt to generate a multivariable risk-prediction mod
PMID 24374547

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma.

Zhu AX1, Rosmorduc O2, Evans TR2, Ross PJ2, Santoro A2, Carrilho FJ2, Bruix J2, Qin S2, Thuluvath PJ2, Llovet JM2, Leberre MA2, Jensen M2, Meinhardt G2, Kang YK2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.J Clin Oncol.2014 Dec 29. pii: JCO.2013.53.7746. [Epub ahead of print]
PURPOSE: To compare the clinical outcomes of sorafenib plus either erlotinib or placebo in patients with advanced hepatocellular carcinoma (HCC) in a multicenter, multinational, randomized, phase III trial.PATIENTS AND METHODS: Patients with advanced HCC and underlying Child-Pugh class A cirrhosis,
PMID 25547503

Final overall survival results from a phase III, randomised, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804).

Zhao H1, Fan Y, Ma S, Song X, Han B, Cheng Y, Huang C, Yang S, Liu X, Liu Y, Lu S, Wang J, Zhang S, Zhou C, Wang M, Zhang L; on behalf of the INFORM investigators..
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.J Thorac Oncol.2014 Dec 24. [Epub ahead of print]
BACKGROUND:: The results of the INFORM study (NCT00770588; C-TONG 0804), which compared gefitinib and placebo as maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) without disease progression after first-line chemotherapy, were published previously. The objective of thi
PMID 25546556